These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17970195)

  • 41. Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques.
    Ishii T; Haga S
    Acta Neuropathol; 1976 Nov; 36(3):243-9. PubMed ID: 795258
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-throughput epitope profiling of antibodies in the plasma of Alzheimer's disease patients using random peptide microarrays.
    Sim KY; Park SH; Choi KY; Park JE; Lee JS; Kim BC; Gwak J; Song WK; Lee KH; Park SG
    Sci Rep; 2019 Mar; 9(1):4587. PubMed ID: 30872784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of immune complexes and autoantibodies to serotonin and dopamine in patients with Alzheimer's disease.
    Davydova TV; Mikovskaya OI; Fomina VG; Voskresenskaya NI; Doronina OA
    Bull Exp Biol Med; 2002 Jul; 134(1):23-5. PubMed ID: 12459860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating autoantibody to mature neurons and astrocytes of humans and some mammals present in a demented patient with autoimmune disorder.
    Kaneko K; Seki K; Ishida K; Uchihara T; Kanda T; Inuzuka T; Miyatake T
    Eur Neurol; 1993; 33(6):450-3. PubMed ID: 7508394
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
    McIntyre JA; Chapman J; Shavit E; Hamilton RL; Dekosky ST
    Autoimmunity; 2007 Jul; 40(5):390-6. PubMed ID: 17612901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postmortem brains reveal similar but not identical amyloid precursor protein-like immunoreactivity in Alzheimer compared with other dementias.
    Webster MT; Francis PT; Procter AW; Stratmann GC; Doshi R; Mann DM; Bowen DM
    Brain Res; 1994 May; 644(2):347-51. PubMed ID: 8050048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain-reactive autoantibodies are nearly ubiquitous in human sera and may be linked to pathology in the context of blood-brain barrier breakdown.
    Levin EC; Acharya NK; Han M; Zavareh SB; Sedeyn JC; Venkataraman V; Nagele RG
    Brain Res; 2010 Jul; 1345():221-32. PubMed ID: 20546711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunological indices in presenile Alzheimer's disease.
    Tavolato B; Argentiero V
    J Neurol Sci; 1980 Jun; 46(3):325-31. PubMed ID: 6966676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone.
    Hyman BT; Van Hoesen GW; Damasio AR
    Ann Neurol; 1987 Jul; 22(1):37-40. PubMed ID: 2443073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human antibodies reactive with beta-amyloid protein in Alzheimer's disease.
    Gaskin F; Finley J; Fang Q; Xu S; Fu SM
    J Exp Med; 1993 Apr; 177(4):1181-6. PubMed ID: 8459212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-NGF autoantibodies and NGF in sera of Alzheimer patients and in normal subjects in relation to age.
    Dicou E; Vermersch P; Penisson-Besnier I; Dubas F; Nerrière V
    Autoimmunity; 1997; 26(3):189-94. PubMed ID: 9550286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease.
    Marcello A; Wirths O; Schneider-Axmann T; Degerman-Gunnarsson M; Lannfelt L; Bayer TA
    Neurobiol Aging; 2011 Aug; 32(8):1379-87. PubMed ID: 19781815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease.
    Kokkonen N; Herukka SK; Huilaja L; Kokki M; Koivisto AM; Hartikainen P; Remes AM; Tasanen K
    J Invest Dermatol; 2017 Jan; 137(1):71-76. PubMed ID: 27650606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glial fibrillary acidic protein stimulates proliferation and immunoglobulin synthesis of lymphocytes from Alzheimer's disease patients.
    Nakamura K; Takeda M; Tanaka T; Tanaka J; Kato Y; Nishinuma K; Nishimura T
    Methods Find Exp Clin Pharmacol; 1992 Mar; 14(2):141-9. PubMed ID: 1598026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma concentrations of glutamate and its metabolites in patients with Alzheimer's disease.
    Miulli DE; Norwell DY; Schwartz FN
    J Am Osteopath Assoc; 1993 Jun; 93(6):670-6. PubMed ID: 8102356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of anti-cerebral autoantibodies in schizophrenia and Alzheimer's disease.
    Sugiura M; Yokoi Y; Maruyama S; Ishido T; Tokunaga Y; Sasaki K
    J Clin Lab Immunol; 1989 Jan; 28(1):1-3. PubMed ID: 2657070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HLA antigens in Alzheimer's disease.
    Sulkava R; Koskimies S; Wikström J; Palo J
    Tissue Antigens; 1980 Aug; 16(2):191-4. PubMed ID: 7466786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease.
    Angelis P; Scharf S; Mander A; Vajda F; Christophidis N
    Neurosci Lett; 1998 Mar; 244(2):106-8. PubMed ID: 9572596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Content of autoantibodies to bradykinin and beta-amyloid(1-42) as a criterion for biochemical differences between Alzheimer's dementias.
    Myagkova MA; Gavrilova SI; Lermontova NN; Kalyn YB; Selezneva ND; Zharikov GA; Kolykhalov IV; Abramenko TV; Serkova TP; Bachurin SO
    Bull Exp Biol Med; 2003 Jul; 136(1):49-52. PubMed ID: 14534609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Redox-reactive antiphospholipid antibody differences between serum from Alzheimer's patients and age-matched controls.
    McIntyre JA; Wagenknecht DR; Ramsey CJ
    Autoimmunity; 2009; 42(8):646-52. PubMed ID: 19886736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.